Literature DB >> 9559742

The use of processed pericardial tissue in anterior ocular segment reconstruction.

O D Schein1.   

Abstract

PURPOSE: To report the use of processed pericardial tissue in reconstructing the anterior ocular segment.
METHOD: Three case reports. RESULT: Processed pericardial tissue was found to be a helpful adjunct in providing tectonic support and promoting epithelialization in the cases described.
CONCLUSION: Processed pericardial tissue has potential application to a variety of anterior ocular segment conditions.

Entities:  

Mesh:

Year:  1998        PMID: 9559742     DOI: 10.1016/s0002-9394(99)80197-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Use of autologous fascia lata as a natural biomaterial for tectonic support in surgically induced necrotizing scleritis.

Authors:  H Kobtan
Journal:  Eye (Lond)       Date:  2015-01-30       Impact factor: 3.775

2.  Surgical treatment of necrotic scleral calcification using combined conjunctival autografting and an amniotic membrane inlay filling technique.

Authors:  B-H Kim
Journal:  Eye (Lond)       Date:  2011-08-26       Impact factor: 3.775

3.  Corneal lamellar grafting to repair late complications of mitomycin C trabeculectomy.

Authors:  Takeo Fukuchi; Hidenobu Matsuda; Jun Ueda; Akiko Yamada; Kieko Suda; Haruki Abe
Journal:  Clin Ophthalmol       Date:  2010-04-26

Review 4.  Delayed manifestation of bilateral scleral thinning after I-BRITE(®) procedure and review of literature for cosmetic eye-whitening procedures.

Authors:  Majid Moshirfar; Michael V McCaughey; Carlton R Fenzl; Luis Santiago-Caban; Gregory D Kramer; Nick Mamalis
Journal:  Clin Ophthalmol       Date:  2015-03-04

5.  Preserved Corneal Lamellar Grafting Reduces Inflammation and Promotes Wound Healing in a Scleral Defect Rabbit Model.

Authors:  Kyoung Woo Kim; Jin Suk Ryu; Jun Yeob Kim; Mee Kum Kim
Journal:  Transl Vis Sci Technol       Date:  2020-06-29       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.